Researchers have developed a new vaccine that is capable
of overcoming the plague, if the virus accidentally escaped from the
pharmaceutical plant. Only 74 cases of polio reported worldwide last year.
Public health officials expect the disease causes paralysis was completely
eradicated. To make sure there will not be another outbreak, the goal is to
continue to provide the vaccine to every child.
But the virus that causes polio is maintained in
biocontainment facilities where the virus was processed into an inactive form
which is a seed for the vaccine. And there is a small possibility that the
virus was able to escape and infiltrate into the general population.
But now, a second-generation vaccine that was developed
by a team of researchers led by the Netherlands, will eliminate the risk of
polio outbreaks caused by a virus that escapes. In the journal PLoS Pathogens,
researchers report the development of a vaccine to cold temperature adjustment
thus making it unable to multiply in the human body.
This type of virus that is used to create a new vaccine
virus is engineered such that it can only grow at temperatures around 30
degrees Celsius. It was much colder than normal human body temperature of 37
degrees C. Researchers say, beyond the threat of an outbreak, the current
injectable vaccine spplies are inadequate, and anyway the cost of production is
quite expensive.
But the researchers noted that the vaccine is adapted to
cold temperatures could ultimately be cheaper cost of production and more doses
could be produced. "So, it would be nice if we could produce it in many
countries around the world. And for such a purpose, we really need a virus that
is more secure, not so ferociously, and does not cause disease," he
explained. A number of countries with active pharmaceutical industries such as
India, can enter the market, making a large number of polio vaccine at an
affordable cost.

Tidak ada komentar:
Posting Komentar